{"biological_condition":["Treatment: 300 nM Crizotinib for 3 hrs"],"cell_line":["JB6 (Human anaplastic large cell lymphoma)"],"identifier":["EXP053278","GSE117164","GSM3272739"],"jaspar_id":["MA0144.2"],"prediction_models":["DAMO"],"tf_id":"EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3","tf_name":"STAT3","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":-3.69805248743171,"distance_threshold":"47","jaspar_id":"MA0144","jaspar_version":"2","score_threshold":"87.8","total_tfbs":"601","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3/EXP053278.JB6_Human_anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.png"}]}],"total_peaks":"1473"}